Skip to main content
Advanced Technical IVT

tumor treating fields

Also written as: TTFields — Tumor Treating Fields

A novel therapeutic modality using alternating electric fields to disrupt cancer cell division, requiring careful explanation of mechanism.

Full Definition

Tumor treating fields (TTFields) represent a novel cancer treatment modality that uses low-intensity, intermediate-frequency alternating electric fields to disrupt cancer cell mitosis. Delivered through arrays placed on the scalp, TTFields therapy is FDA-approved for newly diagnosed and recurrent glioblastoma. Editors must understand the unique aspects of this therapy, including the requirement for continuous wearing of arrays, skin care considerations, and quality-of-life implications. The technology requires precise terminology when describing field application, compliance monitoring, and integration with standard therapies.

Usage

Usage note: Capitalize 'TTFields' when used as abbreviation; specify duration of daily use when reporting compliance data.

In Context

  • "Tumor treating fields therapy was initiated after completion of concurrent chemoradiotherapy." — Treatment protocol documentation
  • "Patient compliance with tumor treating fields averaged 18 hours per day throughout the treatment period." — Clinical trial efficacy report

Also known as

TTFields alternating electric field therapy NovoTTF therapy

Contrasted with

conventional chemotherapy radiation therapy

Don't confuse with

electric field therapy electromagnetic therapy radiofrequency therapy

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON